Navigation Links
BioMarin Announces Fourth Quarter and Full Year 2010 Financial Results
Date:2/17/2011

expense and certain nonrecurring material items.  The reconciliation of the non-GAAP measures to the GAAP net income in the fourth quarter and full year 2010 is detailed in the table provided near the end of the press release.

GAAP net income for the year ended December 31, 2010 was $205.8 million ($1.73 per diluted share), compared to GAAP net loss of $0.5 million ($0.00 per diluted share) for the year ended December 31, 2009.  Non-GAAP net income was $34.8 million ($0.33 per diluted share) for the year ended December 31, 2010, compared to non-GAAP net income of $47.1 million ($0.46 per diluted share) for the year ended December 31, 2009.

As of December 31, 2010, BioMarin had cash, cash equivalents and short and long-term investments totaling $402.3 million, as compared to $440.9 million at the end of September 30, 2010.  The decrease in the fourth quarter of 2010 was attributable to debt conversion expense of $13.7 million, a milestone payment of $11.0 million to the former LEAD shareholders related to the acceptance of the IND for BMN-673 and increases in working capital, primarily related to planned inventory builds.  During 2011, the company expects to remain cash flow neutral to slightly positive.

"We have made significant progress on advancing our pipeline and remain committed to investing in future growth in the coming years.  We recently initiated the pivotal Phase III trial for GALNS as well as the Phase I/II trials for BMN-701 for Pompe disease and BMN-673 for genetically-defined cancers," said Jean-Jacques Bienaime, Chief Executive Officer of BioMarin.  "Our commercial business is growing steadily, and we continue to see growth opportunities for each of our products. Naglazyme sales in the fourth quarter of 2010 were artificially low due to the timing of government orders from Brazil and will result in higher comparable revenues in the first quarter of 2011. However, Naglazyme patient growth continues t
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. BioMarin Initiates Pivotal Phase 3 Trial for GALNS for the Treatment of MPS IVA
2. BioMarin to Host Fourth Quarter and Full Year 2010 Financial Results
3. BioMarin Initiates Phase 1/2 Trial for BMN 701 for the Treatment of Pompe Disease
4. BioMarin Initiates Phase 1/2 Trial for BMN 673 for the Treatment of Genetically-Defined Cancers
5. BioMarin to Present at the J.P. Morgan 29th Annual Healthcare Conference
6. BioMarin to Present at the Deutsche Bank 2010 BioFEST Conference
7. BioMarin Completes Partial Exchange of Convertible Notes Due 2013 for Common Stock
8. BioMarin Announces Third Quarter 2010 Financial Results
9. BioMarin to Host a Research and Development Day on October 19th
10. BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
11. BioMarin to Present at the UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... CORAL SPRINGS, Florida , April 21, 2015 /PRNewswire/ ... in the U.S. are expected to grow at a ... for companies & vendors that provide technology services for ... Companies in focus today are: Surna Inc. (OTC: SRNA), ... (OTC: MJNA), Breathe, E-Cigs Corp. (OTC: BVAP), 22 nd ...
(Date:4/21/2015)... , April 21, 2015  Decision Diagnostics ... administrator and the exclusive worldwide sales, service and ... the FDA-cleared Green Alternative Strip, specifically designed to ... LifeScan OneTouch Ultra family of glucose testing meters, ... announced today that Johnson & Johnson/Lifescan has requested ...
(Date:4/21/2015)... , April 21, 2015  Navitas has launched ... a wide range of offerings for life sciences clients. ... an integrated platform enabling seamless flow of data across ... the Aviator launch, Navitas worked closely with Oracle to ... and Oracle,s CTMS in the Cloud. ...
Breaking Medicine Technology:New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 2New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 3New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 4New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 5New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 6New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 7Decision Diagnostics Shrugs Off New Attack As Johnson & Johnson Panics In Patent Case 2Decision Diagnostics Shrugs Off New Attack As Johnson & Johnson Panics In Patent Case 3Navitas Launches Aviator - Cloud Based Platforms for Oracle Solutions 2Navitas Launches Aviator - Cloud Based Platforms for Oracle Solutions 3Navitas Launches Aviator - Cloud Based Platforms for Oracle Solutions 4
(Date:4/21/2015)... Los Angeles, CA (PRWEB) April 21, 2015 ... Instead, it opened its doors today in the leafy, ... with a refreshed look and a new theme of “Disconnect ... the new owner of the award-winning day spa, announces ... in time for special Mother’s Day offerings that help celebrate ...
(Date:4/21/2015)... Utah (PRWEB) April 21, 2015 Zane ... businesses, announced today its CEO Rick Lindquist has been ... for 2015. , According to Rick Lindquist, “There is ... industry, and Zane Benefits’ small business solutions are at ... recognition provided by Employee Benefit Adviser’s Rising Stars.” , ...
(Date:4/21/2015)... has released a new blog post explaining the importance of ... on a uto insurance prices . , Drivers ... for advantageous auto insurance discounts. Clients can now review multiple ... will also help them get the best rates in their ... cost coverage is no longer difficult as there are multiple ...
(Date:4/21/2015)... Optimity Advisors ( Optimity), ... that helps clients in complex industries navigate rapid ... Association of Community Affiliated Plans (ACAP) ... 58 local, not-for-profit, community-affiliated Safety Net Health Plans ... primarily enrolled in public or state-sponsored coverage programs, ...
(Date:4/21/2015)... Quark Software Inc. has introduced ... solution that enables large enterprises to streamline the ... With Quark Procedure Management, corporate writers and subject ... to save, search and update, which is critical ... issues. Examples of policies and procedures include employee ...
Breaking Medicine News(10 mins):Health News:Larchmont Sanctuary Spa Revealed as New Name For Neighborhood Spa; New Owner, New Eco Offerings & New Theme: “Disconnect to Reconnect” 2Health News:Larchmont Sanctuary Spa Revealed as New Name For Neighborhood Spa; New Owner, New Eco Offerings & New Theme: “Disconnect to Reconnect” 3Health News:Zane Benefits’ CEO Named Top 20 Rising Stars 2Health News:Auto Insurance Quotes Offer Excellent Security for A Car 2Health News:Optimity Advisors Named Preferred Vendor by the Association of Community Affiliated Plans (ACAP) 2Health News:Quark Software Inc. Introduces Procedure Management Solution for Global 2000 2Health News:Quark Software Inc. Introduces Procedure Management Solution for Global 2000 3
... By Jenifer Goodwin HealthDay Reporter , THURSDAY, ... falling behind on your mortgage payments hurts more than just ... with the struggle can also harm your physical and psychological ... on nearly 2,500 Americans who took part in the Health ...
... News) -- Most Americans consume too much sodium, and new ... of dietary salt, according to a new study by federal ... with increased risk of high blood pressure, which can lead ... people aged 2 years and older should limit daily sodium ...
... University of Houston (UH) are recommending a new strategy for ... diseases. In an invited review published in the ... at the Center for Nuclear Receptors and Cell Signaling (CNRCS) ... the team,s 1996 discovery of the estrogen receptor beta (ERβ). ...
... 20 (HealthDay News) -- There,s a suicide every 15 minutes in ... her own life there are many more who think about, plan ... The analysis of 2008-09 data from the National Survey on Drug ... range from about 1 in 50 adults in Georgia (2.1 percent) ...
... HOUSTON -- (Oct. 20, 2011) -- Bioengineers from Rice University ... a new "law of biology" can predict when a critically ... treatment is likely to prevent it. "We want to ... the principal investigator on a new $1.5 million grant from ...
... announce findings published in the October 20 issue of ... the inhibition of both microRNA-33a and microRNA-33b (miR-33a/b) with ... cause a sustained increase in high density lipoprotein cholesterol ... in the last decade has opened new insights for ...
Cached Medicine News:Health News:Foreclosure Crisis Threatening Americans' Health: Study 2Health News:Foreclosure Crisis Threatening Americans' Health: Study 3Health News:U.S. Diet Still Has Too Much Salt, CDC Warns 2Health News:New drug strategies for Alzheimer's, multiple sclerosis examined at UH 2Health News:Suicide Rates Vary by Region: CDC 2Health News:Cloudy with a chance of sudden death 2Health News:Cloudy with a chance of sudden death 3Health News:Novel therapeutic target identified to decrease triglycerides and increase 'good' cholesterol 2
Used to remove wrinkles from sections and for reorientating embedded tissue....
... CO-Oximeter Control (Bayer 800 Series) is ... monitoring the performance of blood gas, ... 270 and 800 series) instrumentation. This ... Bayer 800 Rapidlab Series instruments in ...
Prevents formation of microscopic ice crystals and sample distortion caused by slow freezing of hyperosmolar tissue samples in conventional cyrostats....
Liquichek Blood Gas Plus CO-Oximeter Control (IL Synthesis Series) is a combination control for use in monitoring the performance of blood gas, ion-selective electrode, biosensor and CO-Oximetry anal...
Medicine Products: